Jump to content

Blood test has potential to catch lung cancer early


Recommended Posts

Blood test has potential to catch lung cancer early

By ALAN BAVLEY / McClatchy Newspapers


Maybe the biggest benefit Christopher Ottinger sees from the new lung cancer test he offers his patients isn't the occasional positive result that suggests a tumor may be forming.

It's the negative results that indicate patients are cancer-free.

"These are people who smoke and I've just given them a new reason to continue smoking. But I get just the opposite response," the Lenexa, Kan., family practice doctor said.

"The great result is people saying they're going to quit smoking. They say, 'You've given me a second life.'"

Ottinger is an early adopter of a blood test that has the potential to catch lung cancers years before tumors can be detected through standard screenings by chest X-rays or CT scans.

Whether longtime smokers and other patients at high risk actually benefit from early screening for lung cancer remains controversial among cancer specialists.

But proponents of the test, developed by Oncimmune, a British company with U.S. headquarters in De Soto, Mo., say it's an aid to early detection that may give patients a fighting chance against one of the deadliest cancers.

Lung cancer usually is discovered only after it has progressed and surgery is difficult or impossible. Only 15 percent of lung cancer patients are alive five years after they're diagnosed. More than 150,000 people a year die from lung cancer.

For the past year, Oncimmune has been distributing the test through a small but growing network of physicians. Now it's readying a national rollout. The company is working to get the $475 test covered by Medicare and private insurance plans.

Oncimmune is presenting new research findings this week at the American Society of Clinical Oncology's annual meeting in Chicago. And it has announced plans to introduce the lung cancer test in Britain next year.

The blood test can spot 40 percent of lung cancers, Oncimmune says.

It does this by detecting antibodies produced by a patient's immune system as it reacts to the distinctive proteins shed into the bloodstream by a developing cancer.

"The immune system of the body is exquisitely sensitive to things that are not like itself. It recognizes that these proteins are not right," said John Robertson, a cancer specialist at the University of Nottingham who led the research on the blood test.

A year from now, Oncimmune expects to launch a similar blood test in the United States for breast cancer. And its researchers are working on blood tests for ovarian, colon and liver cancer.

"The whole idea is to catch (cancers) at a point where they're much more localized and treatable," said Dan Calvo, chief executive office for Oncimmune in the United States. "Not only is it saving lives, but it's saving the system by treating something earlier."

But not all experts are persuaded that a blood test for lung cancer will benefit patients.

"It might be premature to say everybody (at risk) should have this blood test to see if they have lung cancer," said Chao Huang, a lung cancer specialist at the University of Kansas Hospital.

"It may tell us that a patient is at risk of cancer and to be on the lookout. But in that case, it could be a difficult clinical management problem. If you can't detect the cancer on CT, how do you treat it?"

Huang said studies have shown that CT screenings do lead to earlier detection of lung cancer, but it's unclear whether survival odds improve.

"There's still debate over the benefit of screening by CT scan," he said.

Ottinger, who serves as a paid adviser to Oncimmune, has been offering the blood test since May of last year to patients who have been smoking for 15 years or longer.

He's seen smokers who have waited until they've had serious symptoms before coming in for a checkup.

"People start coughing up blood, losing weight. They have trouble breathing," he said. "They're either denying it or not noticing it."

By that time they may have tennis-ball-size tumors in their lungs.

"It's nearly too late to assist a patient at that point," he said. "Oftentimes, you're providing palliative care."

Several of Ottinger's patients have had positive blood tests for lung cancer. They are being monitored by periodic CT scans.

But for patients with negative results, the test has been more influential than any of the advice he's given to quit smoking.

"You can talk till you're blue in the face," Ottinger said. "This has a greater impact."

Read more: http://www.bellinghamherald.com/2010/06 ... z0ranDpg6F

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.